S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
These 2 Healthcare Stocks Have Doubled in 2023
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:IQ

iQIYI - IQ Price Target & Analyst Ratings

$7.31
+0.61 (+9.10%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$6.91
$7.35
50-Day Range
$2.44
$7.31
52-Week Range
$1.65
$7.35
Volume
22.59 million shs
Average Volume
24.71 million shs
Market Capitalization
$5.85 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.31

iQIYI Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 7 Analyst Ratings

Consensus Analyst Price Target

$4.31
-41.02% Downside
High Prediction$6.00
Average Prediction$4.31
Low Prediction$2.60
TypeCurrent
2/2/22 to 2/2/23
1 Month Ago
1/3/22 to 1/3/23
3 Months Ago
11/4/21 to 11/4/22
1 Year Ago
2/2/21 to 2/2/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$4.31$3.99$5.09$12.87
Predicted Upside-41.02% Downside32.55% Upside42.86% Upside16.70% Upside
Get iQIYI Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IQ and its competitors with MarketBeat's FREE daily newsletter.


IQ Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IQ Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

iQIYI Stock vs. The Competition

TypeiQIYIConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.43
2.51
2.46
Consensus RatingHoldBuyHold
Predicted Upside-41.02% Downside77.72% Upside8.10% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/18/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$2.80 ➝ $5.10-6.25%
1/9/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$4.40 ➝ $4.90-19.28%
12/7/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$7.00 ➝ $6.00+80.18%
11/24/2022Nomura
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$3.90 ➝ $2.60+4.84%
11/23/2022HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$4.00 ➝ $2.60+7.00%
10/14/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$6.50 ➝ $4.00+72.41%
9/1/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$4.80+31.15%
8/31/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$7.00 ➝ $6.00+69.01%
8/23/2022Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform$2.80-22.65%
1/10/2022OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMixed ➝ Negative
8/13/2021KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$26.00 ➝ $19.00+100.63%
5/18/2021CLSA
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Outperform$25.50 ➝ $16.00+14.70%
4/29/2021Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$18.50 ➝ $17.00+9.32%
1/5/2021New Street Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jin Yoon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$23.00+27.49%
12/24/2020Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$25.00 ➝ $18.00+5.20%
12/24/2020National Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$23.20+35.59%
10/5/2020Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Bo Pei CFA
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
(Data available from 2/2/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












IQ Price Target - Frequently Asked Questions

What is iQIYI's consensus rating and price target?

According to the issued ratings of 7 analysts in the last year, the consensus rating for iQIYI stock is Hold based on the current 1 sell rating, 2 hold ratings and 4 buy ratings for IQ. The average twelve-month price prediction for iQIYI is $4.31 with a high price target of $6.00 and a low price target of $2.60. Learn more on IQ's analyst rating history.

Do Wall Street analysts like iQIYI more than its competitors?

Analysts like iQIYI less than other Consumer Discretionary companies. The consensus rating for iQIYI is Hold while the average consensus rating for consumer discretionary companies is Buy. Learn more on how IQ compares to other companies.

Is iQIYI being upgraded by Wall Street analysts?

Over the previous 90 days, iQIYI's stock had 1 upgrade by analysts.

Does iQIYI's stock price have much upside?

According to analysts, iQIYI's stock has a predicted upside of 13.32% based on their 12-month price targets.

What analysts cover iQIYI?

iQIYI has been rated by HSBC, JPMorgan Chase & Co., Morgan Stanley, Nomura, and The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:IQ) was last updated on 2/2/2023 by MarketBeat.com Staff